Open AccessCombined use of direct antiviral drugs - paritrapevir, ritonavir, ombitasvir and dasabuvir in the treatment of patients with HCV-deterministic compensated cirrhosis in real clinical practice
Author(s) -
Ю. М. Амбалов,
А. П. Коваленко,
О. А. Пшенецкая,
О. А. Рязанова
Publication year - 2018
Publication title -
medicinskij vestnik ûga rossii
Language(s) - English
Resource type - Journals
eISSN - 2618-7876
pISSN - 2219-8075
DOI - 10.21886/2219-8075-2018-9-2-88-91
Subject(s) - ombitasvir , dasabuvir , paritaprevir , medicine , ritonavir , cirrhosis , gastroenterology , hepatocellular carcinoma , ribavirin , hepatitis c virus , hepatitis c , virology , viral load , virus , antiretroviral therapy